| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Ashish Siri Ram Khanna last filed a Form 4 in February 2021, as Director at BOLT. Ashish Siri Ram Khanna's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 1,200 shares of BOLT. Net of sales, the BOLT filings show accumulation of 2,200 shares.
Ashish Siri Ram Khanna has 1 Form 4 filing on record in February 2021, as Director at Bolt Biotherapeutics (BOLT), 2021.
The 2 reported transactions were 2 open-market purchases.
Counted by filing, the open-market trades come to 1 purchase worth about $44K and no sales.
The only open-market purchase was 2,200 shares of BOLT at an average $20.00 on February 9, 2021, about $44K.
Shares as reported in the last Form 4 for each company; the most recent is from February 2021. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 9, 2021 | BOLT Bolt Biotherapeutics, Inc. | Director | Buy | 2,200 | $20.00 | $44,000.00 | -220.0% |